Concord Medical Services Holdings Limited (NYSE:CCM) Sees Significant Decrease in Short Interest

Concord Medical Services Holdings Limited (NYSE:CCM) was the target of a significant decline in short interest in the month of October. As of October 15th, there was short interest totaling 6,821 shares, a decline of 37.5% from the September 30th total of 10,916 shares. Based on an average daily volume of 11,855 shares, the short-interest ratio is presently 0.6 days. Approximately 0.3% of the company’s shares are sold short.

Analyst Ratings Changes

CCM has been the subject of several research reports. Wall Street Zen raised shares of Concord Medical Services to a “hold” rating in a research note on Saturday, August 15th. Weiss Ratings reissued a “sell (e+)” rating on shares of Concord Medical Services in a research report on Friday, August 21st. One research analyst has rated the stock with a Sell rating. According to MarketBeat, Concord Medical Services has an average rating of “Sell”.

Concord Medical Services Stock Up 3.1%

Shares of Concord Medical Services stock traded up $0.11 during trading on Monday, reaching $3.68. 3,655 shares of the company traded hands, compared to its average volume of 35,036. The company has a 50 day moving average price of $3.90 and a 200-day moving average price of $4.20. Concord Medical Services has a 1-year low of $2.79 and a 1-year high of $6.80.

Concord Medical Services Company Profile

Concord Medical Services Holdings Limited was a China-based healthcare services company focused primarily on cancer treatment and diagnostic imaging. The company operated and managed medical facilities that provided radiotherapy, diagnostic imaging, and related oncology services, often through partnerships with hospitals and other healthcare institutions.

Its business also included the provision of medical equipment, technology, and management services to healthcare providers. Concord Medical’s facilities and partnerships were concentrated in China, with a focus on expanding access to specialized cancer diagnosis and treatment in major cities and regional medical centers.

Founded in 2006 and headquartered in Beijing, Concord Medical was historically led by founder and chief executive officer Dr.